Intro As I continue the series of articles on the projects we specialize in at SiVan Consulting, I thought I would tackle
Intro This is the second article discussing how to run a benchmarking project. If you haven’t read the first, in which we
Getting a Nature + subscription was one of the best decisions we made this year. For £15 a month we get access
It has been a bit of a writing hiatus as I have been in the middle of delivering a few short, intense
This post/article is worth a read for those interested in the evolution of Pharma Business models: Pharma Exec – The Teva Turnaround
This follows last week’s post (Link) on the impact of M&A and licensing on FDA drug approvals of leading pharmaceutical companies, based
I recently read an interesting paper from Prof. Alexander Schuhmacher et al. on the impact of M&A and licensing on FDA drug
1. Introduction In this project history, I’ll talk about an example of a proactive company preparing for an event several years away,
If you have decided to do a benchmarking exercise and collected a load of data, including primary research, you’re now probably thinking,
This week’s recommendation is a book I’m in the process of reading through a second time: Storytelling with Data: A Data Visualization
Ever find yourself mid-way through a research consulting project and disagreeing on what can be delivered? It’s the start of the year
With the start of the new year, you may look at your company, business unit, or function and decide it is time
Two crucial questions I’ve tackled in numerous projects for new life science products designed for hospitals are: who are the decision-makers, and
Has the influence of finance in biopharma helped or hindered addressing unmet needs and getting treatments to patients? Roy Victor’s book is
Intro You, your internal strategy/research/insights team, and one or more vendors have just wrapped up a project to support a drug, medical